111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.

Détails

ID Serval
serval:BIB_236939345F57
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
Périodique
European Journal of Nuclear Medicine and Molecular Imaging
Auteur(s)
Bombardieri Emilio, Ambrosini Valentina, Aktolun Cumali, Baum Richard P., Bishof-Delaloye Angelica, Del Vecchio Silvana, Maffioli Lorenzo, Mortelmans Luc, Oyen Wim, Pepe Giovanna, Chiti Arturo
ISSN
1619-7089[electronic], 1619-7070[linking]
Statut éditorial
Publié
Date de publication
2010
Volume
37
Numéro
7
Pages
1441-1448
Langue
anglais
Résumé
This document provides general information about somatostatin receptor scintigraphy with (111)In-pentetreotide. This guideline should not be regarded as the only approach to visualise tumours expressing somatostatin receptors or as exclusive of other nuclear medicine procedures useful to obtain comparable results. The aim of this guideline is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of (111)In-pentetreotide scintigraphy.
Mots-clé
In-111-Pentetreotide Scintigraphy, Tumour Imaging, Procedure Guidelines, Neuroendocrine Tumours, Indications, Somatostatin Receptor Scintigraphy, Neuroendocrine Gastroenteropancreatic Tumors, Carcinoid-Tumors, Analog Scintigraphy, Endocrine Tumors, Management, Indium-111-Pentetreotide, Expression, Impact, Gastrinomas
Pubmed
Web of science
Création de la notice
06/07/2010 11:07
Dernière modification de la notice
03/03/2018 14:54
Données d'usage